At one of my companies we were encouraged by our investors to do Phase I (and some Phase II) clinical trials in the Dominican Republic, Mexico, Angola, and other such places.
Back then we did do device studies in Germany because the regulations were at the time quite lax (basically you just needed a German MD to decide it was OK and to actually use the device). They've since tightened up the rules.
Interestingly, in the device case, people who were squeamish about doing studies in poor countries with poor IRBs and such were perfectly happy to do the device studies in Germany. Not sure what to make of that.
Back then we did do device studies in Germany because the regulations were at the time quite lax (basically you just needed a German MD to decide it was OK and to actually use the device). They've since tightened up the rules.
Interestingly, in the device case, people who were squeamish about doing studies in poor countries with poor IRBs and such were perfectly happy to do the device studies in Germany. Not sure what to make of that.